Anna Affini

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
With the very recent market approval of pitolisant (Wakix®), the interest in clinical applications of novel multifunctional histamine H3 receptor antagonists has clearly increased. Since histamine H3 receptor antagonists in clinical development have been tested for a variety of different indications, the combination of pharmacological properties in one(More)
  • 1